Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Leukemia|February 23, 2020
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS indexFabio Efficace, Francesco Cottone, Laura B Oswald, et al.
Leukemia|September 4, 2019
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapyFabio Efficace, Fabio Stagno, Alessandra Iurlo, et al.
The Lancet. Oncology|January 22, 2026
Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trialLisa M Wintner, Monika Sztankay, Hikmat Abdel-Razeq, et al.
Cancer|November 2, 2022
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021Raffaella Origa, Barbara Gianesin, Filomena Longo, et al.
Cancer|October 6, 2023
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemiaFabio Efficace, Francesco Cottone, Betina Yanez, et al.
Cancer|December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromesFabio Efficace, Francesco Cottone, Gregory Abel, et al.
American Journal of Hematology|June 29, 2016
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of diseaseFabio Efficace, Franco Mandelli, Paola Fazi, et al.
European Journal of Haematology|March 4, 2014
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)Emanuele Angelucci, Valeria Santini, Anna Angela Di Tucci, et al.
Plos One|July 8, 2017
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantationRoberto Littera, Gianbenedetto Piredda, Davide Argiolas, et al.
Annals of Hematology|May 3, 2019
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practiceGiovanni Caocci, Olga Mulas, Elisabetta Abruzzese, et al.
Pageof 15